These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [TBL] [Abstract][Full Text] [Related]
4. Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. Jessen ME Anesth Analg; 2006 Dec; 103(6):1365-9. PubMed ID: 17122204 [No Abstract] [Full Text] [Related]
6. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass. de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550 [TBL] [Abstract][Full Text] [Related]
8. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose. Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of heparin-coated circuits with full heparin dose strategy. Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761 [TBL] [Abstract][Full Text] [Related]
10. Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: heparin-coated circuits versus nonheparin-coated circuits. Morishita K; Kawaharada N; Fukada J; Hachiro Y; Kurimoto Y; Fujisawa Y; Saito T; Abe T Artif Organs; 2005 Apr; 29(4):300-5. PubMed ID: 15787624 [TBL] [Abstract][Full Text] [Related]
12. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass. Zhang K; Hu Z; Yang Y; Huang R; Fan H; Sun Z J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):403-6. PubMed ID: 15015647 [TBL] [Abstract][Full Text] [Related]
14. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027 [TBL] [Abstract][Full Text] [Related]
15. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts. Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488 [TBL] [Abstract][Full Text] [Related]
16. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs. Bagge L; Borowiec JW; Thelin S; Hultman J Scand Cardiovasc J; 1997; 31(5):275-81. PubMed ID: 9406294 [TBL] [Abstract][Full Text] [Related]
17. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits. Gunaydin S; Mccusker K; Vijay V J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383 [TBL] [Abstract][Full Text] [Related]